News
What else does weight-loss drug Ozempic do? 5 unexpected health benefits - Emerging scientific research indicates that ...
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become household names in recent years, hailed as revolutionary ...
Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...
Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...
Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...
Denver healthcare providers express concerns about patients losing access to weight loss medications
As GLP-1 weight loss drugs have surged in popularity, the Food and Drug Administration has ordered medical professionals offering compounded versions of these drugs to stop services on April 22.
Eli Lilly surged during Thursday's trading session after promising test results came out of the pharmaceutical company's ...
Injectable drugs require refrigeration when they are stored or transported, and the pill potentially opens up the market ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results